Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lyell Immunopharma (LYEL) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Lyell Immunopharma (LYEL) over the last 6 years, with Dec 2024 value amounting to $261.5 million.

  • Lyell Immunopharma's Shares Outstanding (Diluted Average) rose 42.55% to $18.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year increase of 42.55%. This contributed to the annual value of $261.5 million for FY2024, which is 4.18% up from last year.
  • Per Lyell Immunopharma's latest filing, its Shares Outstanding (Diluted Average) stood at $261.5 million for FY2024, which was up 4.18% from $251.0 million recorded in FY2023.
  • Over the past 5 years, Lyell Immunopharma's Shares Outstanding (Diluted Average) peaked at $261.5 million during FY2024, and registered a low of $13.3 million during FY2020.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $253.2 million, with a median of $251.0 million in 2023.
  • Data for Lyell Immunopharma's Shares Outstanding (Diluted Average) shows a peak YoY surged of 244,107.04% (in 2020) over the last 5 years.
  • Over the past 5 years, Lyell Immunopharma's Shares Outstanding (Diluted Average) (Yearly) stood at $13.3 million in 2020, then spiked by 925.18% to $135.9 million in 2021, then skyrocketed by 81.79% to $247.1 million in 2022, then rose by 1.58% to $251.0 million in 2023, then grew by 4.18% to $261.5 million in 2024.